Dr Reddys Laboratories gains despite reporting 60% slump in Q2 consolidated net profit.
Dr Reddys Laboratories has reported 54.12% fall in its net profit at Rs 313.20 crore for the quarter under review as compared to Rs 682.60 crore for the same quarter in the previous year. Total income of the company decreased by 9.68% at Rs 2691.40 crore for Q2FY17 as compared Rs 2980.00 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported 60.13% fall in its net profit after tax, minority interest and share of profit of associates at Rs 308.90 crore for the quarter ended September 30, 2016 as compared to Rs 774.70 crore for the same quarter in the previous year.
The total income of the company decreased by 10.58% at Rs 3660.10 crore for quarter under review as compared to Rs 4093.10 crore for the quarter ended September 30, 2015.
